Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 905, pseudogene (RNU6-905P) is a genomic locus classified as a pseudogene related to the U6 small nuclear RNA family, located on human chromosome 3[7][9]. Pseudogenes are characterized by their lack of protein-coding potential, and while some may be transcribed, most do not produce functional proteins[2][4]. The U6 small nuclear RNAs are components of the spliceosome, but pseudogenes like RNU6-905P are generally nonfunctional remnants with limited, if any, biological activity. Emerging research indicates some pseudogenes can regulate parental gene expression, participate in RNA-based regulatory networks, or produce small interfering RNAs impacting cellular pathways[2][4], yet there is no specific functional data or clinical implication described for RNU6-905P. It is not regarded as a receptor, enzyme, transporter, or direct therapeutic target. In sum, RNU6-905P is a pseudogene annotation with no known therapeutic, biomarker, or clinical relevance, and is not a valid drug target. If a functional U6 snRNA or a protein-coding gene is intended, a different target name is needed.
Not applicable (not a drug target; see above).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 905, pseudogene (RNU6-905P).